findmyKOL
Clinical trialNCT06729593CompletedPhase 3Interventional

Remdesivir for Severely Ill Inpatients With COVID-19 (An ACTIV-3b/TESICO Treatment Trial)

SponsorNational Institute of Allergy and Infectious Diseases (NIAID)Enrollment87Covid19
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Prof. James Neaton

    INSIGHT Statistical and Coordinating Centre, University of Minnesota

    Study Chair
  • Samuel Brown, MD

    Intermountain Medical Center/University of Utah

    Principal Investigator

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

40 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Banner University Medical Center Tucson (site 206-004), 1625 N. Campbell Avenue

    Tucson, Arizona, United States

  • Ucsf Fresno (site 203-005), 155 N. Fresno Street

    Fresno, California, United States

  • Va Loma Linda Healthcare System (site 074-017), 11201 Benton Street

    Loma Linda, California, United States

  • Cedars-Sinai Medical Center (site 208-002), 8700 Beverly Boulevard

    Los Angeles, California, United States

  • Ronald Reagan Ucla Medical Center (site 203-002), 757 Westwood Plaza

    Los Angeles, California, United States

  • Ucsf Medical Center (site 203-001), Moffit-Long Hospital, 505 Parnassus Ave.

    San Francisco, California, United States

  • Ucsf Medical Center at Mount Zion (site 203-007), 1600 Divisadero St.

    San Francisco, California, United States

  • Stanford University Hospital & Clinics (site 203-003), 300 Pasteur Dr.

    Stanford, California, United States

  • University of Colorado Hospital (site 204-001), 12605 E. 16th Avenue

    Aurora, Colorado, United States

  • Denver Health Medical Center (site 204-004), 780 Delaware Street, Pavilion B

    Denver, Colorado, United States

  • Medstar Health Research Institute (site 009-021), 110 Irving St., Nw.

    Washington D.C., District of Columbia, United States

  • Washington Dc Va Medical Center (site 009-004), 50 Irving Street, Nw.

    Washington D.C., District of Columbia, United States

  • Emory University (site 301-008), Bldg. A, Suite 2236, 1365 Clifton Rd., Ne.

    Atlanta, Georgia, United States

  • Massachusetts General Hospital (site 202-002), 55 Fruit Street

    Boston, Massachusetts, United States

  • Baystate Medical Center (site 201-001), Critical Care Research, 759 Chestnut Street

    Springfield, Massachusetts, United States

  • Columbia University Irving Medical Center (site 301-027), 177 Fort Washington Ave.

    New York, New York, United States

  • Mount Sinai Medical Center (site 301-012), Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place

    New York, New York, United States

  • Montefiore Medical Center - Moses Hospital (site 206-001), 111 E. 210th Street

    The Bronx, New York, United States

  • Montefiore Medical Center - Weiler Campus (site 206-003), 111 E. 210th Street

    The Bronx, New York, United States

  • Duke University Hospital (site 301-006), 2301 Erwin Road

    Durham, North Carolina, United States

  • Wake Forest Baptist Health (site 210-001), Medical Center Blvd

    Winston-Salem, North Carolina, United States

  • University of Cincinnati Medical Center (site 207-003), 234 Goodman Street, Ml 0740

    Cincinnati, Ohio, United States

  • Cleveland Clinic Fairview Hospital (site 207-005), 18101 Lorain Ave.

    Cleveland, Ohio, United States

  • Cleveland Clinic Foundation (site 207-001), 9500 Euclid Ave.

    Cleveland, Ohio, United States

  • the Ohio State University Wexner Medical Center (site 207-004), 410 W. 10th Avenue

    Columbus, Ohio, United States

  • Cleveland Clinic Marymount Campus (site 207-006), 12300 Mccracken Road

    Garfield Heights, Ohio, United States

  • Cleveland Clinic Hillcrest Hospital (site 207-007), 6780 Mayfield Road

    Mayfield Heights, Ohio, United States

  • Oregon Health & Science University (site 208-003), 3181 Sw Sam Jackson Park Rd.

    Portland, Oregon, United States

  • Medical University of South Carolina (site 210-002), 96 Jonathan Lucas St., Csb 214

    Charleston, South Carolina, United States

  • Vanderbilt University Medical Center (site 212-001), 1211 Medical Center Drive

    Nashville, Tennessee, United States

  • Baylor, Scott and White Health (site 301-003), Baylor University Medical Center, 3500 Gaston Ave.

    Dallas, Texas, United States

  • Houston Methodist Hospital (site 301-028), 6565 Fannin Street

    Houston, Texas, United States

  • Texas Heart Institute (site 301-017), 6770 Bertner, Mc4-266

    Houston, Texas, United States

  • University of Texas Health Science Center (site 203-006), 7000 Fannin St.

    Houston, Texas, United States

  • Intermountain Medical Center (site 211-001), 5121 South Cottonwood Street

    Murray, Utah, United States

  • University of Utah Hospital (site 211-002), 50 North Medical Drive

    Salt Lake City, Utah, United States

  • Uva School of Medicine (site 210-003), University of Virginia Health System, University Hospital, 1215 Lee St.

    Charlottesville, Virginia, United States

  • Harborview Medical Center (site 208-001), 325 9th Ave.

    Seattle, Washington, United States

  • Swedish Medical Center (site 208-005), 747 Broadway

    Seattle, Washington, United States

  • West Virginia University Medicine (site 301-023), One Medical Center Drive

    Morgantown, West Virginia, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
20 Apr 2021
Primary completion
22 Aug 2022
Completion
20 Nov 2022
Last update posted
9 Oct 2025
Registered enrollment
87
Registry id
NCT06729593

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.